Intranasal Insulin: Clinical Trials

35 trials of Intranasal Insulin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 3 unknown, 2 active not recruiting, 2 recruiting. 15 Phase 2, 9 Not applicable, 9 Phase 1, 3 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 215Completed 12, Recruiting 2, Unknown 1
Not applicable9Completed 5, Active not recruiting 2, Not yet recruiting 1, Unknown 1
Phase 19Completed 8, Withdrawn 1
Phase 33Completed 2, Recruiting 1
Early Phase 11Completed 1
Phase 41Completed 1

Follow Intranasal Insulin: new trials by email Literature Review of Intranasal Insulin trials Research Report on Intranasal Insulin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Exercise and Intranasal Insulin in Type 2 Diabetes
Intranasal Insulin, Intranasal Placebo, High Intensity Exercise - Type 2 Diabetes, Insulin Sensitivity/Resistance
Phase 2 / Phase 3RecruitingRutgers, The State University of New Jersey602026-08-032026-06-30
Dopamine and Insulin in Psychosis
Intranasal Insulin, Placebo, Low dose insulin infusion - First Episode Psychosis (FEP)
Not applicableNot yet recruitingMedical University of Vienna462026-01-012025-11-28
Evaluation Study of New Compounds With Potential Use in Schizophrenia
URB597, intranasal Insulin, Cannabidiol CR - Schizophrenia
Phase 1WithdrawnCentral Institute of Mental Health, Mannheim2025-01-312025-03-21
Pre-operative Intra-nasal Dexmedetomidine or Insulin for Prevention of Early Post-operative Cognitive Dysfunction in Patients Undergoing Elective Coronary Artery Bypass Graft.
intranasal saline group, intranasal insulin, Intranasal dexmedetomidine - Post Operative Cognitive Dysfunction
Early Phase 1CompletedMinia University1502024-12-272026-08-25
Intranasal Insulin for Posttraumatic Stress Disorder
Intranasal insulin, Placebo - PTSD
Phase 2CompletedVA Connecticut Healthcare System102024-10-312026-07-13
Effects of Antipsychotics on Brain Insulin Action in Females
Olanzapine 2.5Mg Oral Tablet, Placebo, Insulin Lispro 100 UNT/ML - Insulin Resistance, Menstrual Cycle
Not applicableActive not recruitingCentre for Addiction and Mental Health152024-06-032026-09-28
COMMETS- Combination MCI Metabolic Syndrome
Semaglutide, Intranasal insulin, Semaglutide placebo - Alzheimer Disease, Mild Cognitive Impairment
Phase 2RecruitingRutgers, The State University of New Jersey802024-01-302026-07-27
Dose-Dependent Effect of Intranasal Insulin in Humans Using Functional Magnetic Resonance Imaging (fMRI)
Intranasal insulin - Healthy
Phase 1CompletedFlorian Schmitzberger62023-11-172024-03-21
Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia
Intranasal insulin, Placebo - Schizophrenia, Healthy
Not applicableActive not recruitingCentre for Addiction and Mental Health202023-04-012026-09-25
Intranasal Insulin Improves Postoperative Neurocognitive Disorders in Elderly Patients
Intranasal insulin, Intranasal saline - Postoperative Neurocognitive Disorders
Not applicableUnknownFirst Affiliated Hospital Xi'an Jiaotong University4382022-11-072022-11-14
Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants
Intranasal insulin - Out-Of-Hospital Cardiac Arrest, Healthy
Phase 1CompletedRobert Silbergleit242021-10-042026-03-27
Is Brain Insulin Resistance a Feature of the Biology of Depression in Adolescents
Humalog, Saline nasal spray - Major Depressive Disorder, Depression
Not applicableCompletedCentre for Addiction and Mental Health242021-09-012026-03-31
Intranasal Insulin for COVID-19-related Smell Loss
Insulin - Anosmia, Smell Loss
Phase 3CompletedUniversidad Panamericana272021-01-042022-07-18
Intranasal Insulin and Olanzapine Study in Healthy Volunteers
OLANZapine 2.5 MG, Placebo, Insulin Lispro 100 UNT/ML - Healthy Controls
Phase 1CompletedCentre for Addiction and Mental Health462019-10-222026-10-19
Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders
Intranasal Insulin - Psychosis, Schizophrenia
Phase 2CompletedMclean Hospital872019-10-012026-09-03
"Effect of Central Insulin Administration on Whole-body Insulin Sensitivity in Women"
intranasal insulin, Placebo spray - Insulin Sensitivity
Not applicableCompletedUniversity Hospital Tuebingen292019-04-212021-09-05
Effect of Intranasal Insulin on Postoperative Cognitive Dysfunction
Intranasal insulin - Middle Aged Patients
UnknownMinia University572019-02-252019-11-06
PINIT Study: Primary Intranasal Insulin Trial
intranasal insulin, Placebo - Diabetes Mellitus, Type 1
Phase 2CompletedTechnical University of Munich382018-05-252021-06-22
Effect of Intranasal Insulin on Cognitive Processes and Appetite
Intranasal Insulin, Intranasal Placebo - Obesity
Not applicableCompletedUniversity of Birmingham642018-04-232019-05-02
Raclopride-PET/MRT
intranasal insulin, Placebo - Diabetes Mellitus, Type 2
Not applicableCompletedUniversity Hospital Tuebingen242017-02-202024-05-14

Showing 20 of 35. Sign in to see all of them.

Conditions studied

Insulin Resistance (12)  ·  Diabetes Mellitus, Type 2 (6)  ·  Diabetes Mellitus (4)  ·  Schizophrenia (4)  ·  Alzheimer Disease (2)  ·  Diabetes Mellitus, Type 1 (2)  ·  Anosmia (1)  ·  Bipolar Disorder (1)  ·  COVID-19 (1)  ·  Cognitive Dysfunction (1)  ·  Dementia (1)  ·  Depression (1)  ·  Depressive Disorder, Major (1)  ·  Hyperinsulinism (1)  ·  Hypogonadism (1)

Sponsors

Centre for Addiction and Mental Health (4)  ·  University Health Network, Toronto (3)  ·  University Hospital Tuebingen (3)  ·  Ajna Hamidovic (2)  ·  Minia University (2)  ·  Rutgers, The State University of New Jersey (2)  ·  Beth Israel Deaconess Medical Center (1)  ·  Bronx Veterans Medical Research Foundation, Inc (1)  ·  Central Institute of Mental Health, Mannheim (1)  ·  First Affiliated Hospital Xi'an Jiaotong University (1)  ·  Florian Schmitzberger (1)  ·  German Diabetes Center (1)  ·  Jeff Burns, MD (1)  ·  Mclean Hospital (1)  ·  Medical University of Vienna (1)

Countries

United States (13)  ·  Canada (7)  ·  Germany (6)  ·  Egypt (2)  ·  Australia (1)  ·  Austria (1)  ·  China (1)  ·  Israel (1)  ·  Mexico (1)  ·  New Zealand (1)  ·  United Kingdom (1)

Top investigators

Ajna Hamidovic, PharmD (1)  ·  Anette-G. Ziegler, Prof. Dr. (1)  ·  Cheryl Bushnell, MD (1)  ·  F. Markus Leweke, MD (1)  ·  Florian Schmitzberger, MD (1)  ·  Gihyun Yoon, MD (1)  ·  Jeffrey M Burns, MD (1)  ·  Julia Golier, MD (1)  ·  Leonard C Harrison, MBBS MD DSc (1)  ·  Maartje SPetter, PhD (1)  ·  Mahavir Agarwal, MBBS, PhD, MD (1)  ·  Mahavir Agarwal, MD, PhD (1)  ·  Margaret K Hahn, PhD, MD (1)  ·  Martin Heni, MD (1)

Results publications

PMID 24101698, PMID 25249577, PMID 25576060, PMID 29557250, PMID 30515210, PMID 31022213, PMID 31689708, PMID 33862126, PMID 34091488, PMID 36441736, PMID 37735274, PMID 42658795

NIH funding

R01DK147509 (1)